How to design a dose-finding study using the continual reassessment method
Abstract Introduction The continual reassessment method (CRM) is a model-based design for phase I trials, which aims to find the maximum tolerated dose (MTD) of a new therapy. The CRM has been shown to be more accurate in targeting the MTD than traditional rule-based approaches such as the 3 + 3 des...
Na minha lista:
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2019-01-01
|
| coleção: | BMC Medical Research Methodology |
| Assuntos: | |
| Acesso em linha: | http://link.springer.com/article/10.1186/s12874-018-0638-z |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
